Gastric cancer treatment guidelines in Japan

Gastric Cancer

Volumn 5, Issue 1, 2002, Pages 1-5

  Nakajima, Toshifusa ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

EBM; Gastric cancer treatment guidelines; Stage oriented treatment; Standard treatment

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL PRACTICE; EVIDENCE BASED MEDICINE; HUMAN; JAPAN; MEDICAL SOCIETY; MULTIMODALITY CANCER THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; STOMACH CANCER; TREATMENT INDICATION; CANCER INVASION; GASTRECTOMY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PATHOLOGY; STOMACH TUMOR; TREATMENT OUTCOME;

COMBINED MODALITY THERAPY; GASTRECTOMY; GUIDELINE ADHERENCE; HUMAN; JAPAN; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; STOMACH NEOPLASMS; TREATMENT OUTCOME; HUMANS;

EID: 0036013457     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101200200000     Document Type: Article

References (24)

1. Tabular analysis of CIH (Cancer Institute Hospital) database
2. In reply to the editor
3. Meta-analysis of adjuvant chemotherapy trials for gastric cancer at the Cancer Institute Hospital, Tokyo
4. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: Revisiting a meta-analysis of randomized trials
5. A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer
6. How to improve survival after diagnosis of gastric cancer? It's back to the drawing board
7. Review of adjuvant chemotherapy for gastric cancer
8. Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer
9. A randomized trial comparing adjuvant fluorouracil, epirubicin and mitomycin with no treatment in operable gastric cancer
10. Multimodality therapy for completely resected (R0) gastric cancer (excluding Japanese trials)
11. Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: A randomized trial
12. Combined intensive chemotherapy and radical surgery for incurable gastric cancer
13. Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: A report from the Italian Group for the Study of Digestive Tract Cancer
14. Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer of the Gastrointestinal Tract
15. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer
16. Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer
17. Randomized comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer
18. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma
19. Evaluation of the extent of lymphadenectomy in a randomized trial of Western-versus Japanese-type surgery in gastric cancer
20. Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial
21. Extended lymph-node dissection for gastric cancer
22. Current advances and changes in treatment strategy may improve survival and quality of life in patients with potentially curable gastric cancer
23. Gastric cancer